Stay updated on Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a study evaluating the effect of nivolumab and daratumumab with or without low-dose cyclophosphamide in patients with relapsed/refractory multiple myeloma. This change reflects the ongoing efforts to combine different immune modulating agents to improve the outcome for heavily pretreated multiple myeloma patients.
    Difference
    0.1%
    Check dated 2024-06-06T14:38:21.000Z thumbnail image
  7. Check
    19 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change likely represents an update or modification in the estimated status of a medical or healthcare-related publication or documentation.
    Difference
    0.0%
    Check dated 2024-05-24T03:21:10.000Z thumbnail image
  8. Check
    21 days ago
    Change Detected
    Summary
    The study status has changed from 'Active, not recruiting' to 'Completed,' and the estimated participation criteria have been updated to actual participation criteria. The study completion date has also been updated from 2023 to 2024, with the actual enrollment number now listed as 62.
    Difference
    47%
    Check dated 2024-05-22T21:00:16.000Z thumbnail image
  9. Check
    43 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:17:50.000Z thumbnail image

Stay in the know with updates to Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page.